Cardiovascular Risk Factors in Coeliac Disease: a Series of Studies
Recruiting now · Not applicable
Conditions studied: Coeliac Disease
In brief
This investigation examines the most important cardiovascular risk factors (e.g., metabolic parameters, body composition) and their changes in coeliac disease. The series of studies allow to assess body composition and cardiovascular risk-related metabolic parameters of newly diagnosed and treated coeliac patients in their complexity and to test if they change during therapy. The interventional part of the investigation aims to answer the question if a dietary intervention mitigates the unfavorable effects of unbalanced diet.
Key facts
- Study ID
- NCT05530070
- Run by
- University of Pecs
- People needed
- 190
- Starts
- 2022-09-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2025-01-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- Chronic conditions:
- Estimated glomerular filtration rate calculated with the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula is <60mL/min/1.73m2 (CKD3 or more severe kidney failure).
- Liver cirrhosis in Child-Pugh class B-C.
- Heart failure (New York Heart Association (NYHA) III-IV).
- Active malignant diseases.
- Any acute diseases or acute deterioration of underlying chronic conditions.
- Diseases that may be associated with clinically relevant malabsorption.
- Refractory CD.
- Pregnancy, lactation.
- Patients unable to understand the essentials of the informed consent.
- Lack of consent or withdrawal of consent.
Where it is running
- First Department of Medicine, Medical School, University of Pécs — Pécs, Baranya, Hungary (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.